Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

HLAG Protein (AA 25-337, partial) (GST tag)

HLAG Origine: Humain Hôte: Escherichia coli (E. coli) Recombinant 90 % ELISA
N° du produit ABIN1047176
  • Antigène Voir toutes HLAG Protéines
    HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
    Type de proteíne
    Recombinant
    Attributs du protein
    AA 25-337, partial
    Origine
    • 14
    • 3
    • 2
    • 1
    Humain
    Source
    • 13
    • 4
    • 2
    • 1
    Escherichia coli (E. coli)
    Purification/Conjugué
    Cette HLAG protéine est marqué à la GST tag.
    Application
    ELISA
    Séquence
    GSHSMRYFSA AVSRPGRGEP RFIAMGYVDD TQFVRFDSDS ACPRMEPRAP WVEQEGPEYW EEETRNTKAH AQTDRMNLQT LRGYYNQSEA SSHTLQWMIG CDLGSDGRLL RGYEQYAYDG KDYLALNEDL RSWTAADTAA QISKRKCEAA NVAEQRRAYL EGTCVEWLHR YLENGKEMLQ RADPPKTHVT HHPVFDYEAT LRCWALGFYP AEIILTWQRD GEDQTQDVEL VETRPAGDGT FQKWAAVVVP SGEEQRYTCH VQHEGLPEPL MLRWKQSSLP TIPIMGIVAG LVVLAAVVTG AAVAAVLWRK KSS
    Attributs du produit
    Please inquire if you are interested in this recombinant protein expressed in E. coli, mammalien cells or by baculovirus infection. Be aware about differences in price and lead time.
    Pureté
    90 %
    Top Product
    Discover our top product HLAG Protéine
  • Commentaires

    The yeast protein expression system is the most economical and efficient eukaryotic system for secretion and intracellular expression. A protein expressed by the mammalian cell system is of very high-quality and close to the natural protein. But the low expression level, the high cost of medium and the culture conditions restrict the promotion of mammalian cell expression systems. The yeast protein expression system serve as a eukaryotic system integrate the advantages of the mammalian cell expression system. A protein expressed by yeast system could be modificated such as glycosylation, acylation, phosphorylation and so on to ensure the native protein conformation. It can be used to produce protein material with high added value that is very close to the natural protein. Our proteins produced by yeast expression system has been used as raw materials for downstream preparation of monoclonal antibodies.

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Concentration
    0.2-2 mg/mL
    Buffer
    Tris-based buffer, 50 % glycerol
    Conseil sur la manipulation
    Repeated freezing and thawing is not recommended. Store working aliquots at 4 °C for up to one week
    Stock
    -20 °C
    Stockage commentaire
    Store at -20 °C for extended storage, conserve at -20 °C or -80 °C
  • Shukla, Swaroop, Srivastava, Weissman: "The mRNA of a human class I gene HLA G/HLA 6.0 exhibits a restricted pattern of expression." dans: Nucleic acids research, Vol. 18, Issue 8, pp. 2189, (1990) (PubMed).

    Geraghty, Koller, Orr: "A human major histocompatibility complex class I gene that encodes a protein with a shortened cytoplasmic segment." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 84, Issue 24, pp. 9145-9, (1988) (PubMed).

  • Antigène
    HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))
    Autre désignation
    HLA class I histocompatibility antigen, alpha chain G protein (HLAG Produits)
    Synonymes
    MHC-G Protein, B-F Protein, B-F-S04 Protein, B-F-S05 Protein, B-F-S06 Protein, B-F-S07 Protein, B-FI Protein, B-FIV Protein, BF2 Protein, BFa2 Protein, BFw-03 Protein, BFw-05 Protein, BFz-01 Protein, major histocompatibility complex, class I, G Protein, MHC BF1 class I Protein, HLA-G Protein, BF1 Protein
    Sujet
    Involved in the presentation of foreign antigens to the immune system. Plays a role in maternal tolerance of the fetus by mediating protection from the deleterious effects of natural killer cells, cytotoxic T lymphocytes, macrophages and mononuclear cells.
    Poids moléculaire
    62.9 kD
    UniProt
    P17693
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
Vous êtes ici:
Support technique